Radical cystectomy is the treatment of choice for invasive bladder Cancer

Journal of the Canadian Urological Association

Volumn 3, Issue 5, 2009, Pages 409-412

  Yafi, Faysal A ^a   Kassouf, Wassim ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70350519093     PISSN: 19116470     EISSN: 19116470     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Marrett LD, de P, Dryer D. Steering Committee of Canadian Cancer Statistics 2008. CMAJ 2008;179: 1163-70.
2. Brennan P, Bogillot O, Cordier S, et al. Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer 2000;86:289-94.
3. Pashos CL, Botteman MF, Laskin BL, et al. Bladder cancer: epidemiology, diagnosis and management. Cancer Pract 2002;10:311-22.
4. Castelao JE, Yuan JM, Gago-Dominguez M, et al. Non-steroidal antiinflammatory drugs and bladder cancer prevention. Br J Cancer 2000;82:1364-9.
5. Chrouser K, Leibovich B, Bergsrtalh E, et al. Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer. J Urol 2006;174:107-10.
6. Steinmaus CM, Nuñez S, Smith AH. Diet and bladder cancer: a meta-analysis of six dietary variables. Am J Epidemiol 2000;151:693-702.
7. Schistosomes, liver flukes and Helicobacter Pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June, 1994. IARC Monogr Eval Carcinog Risks Hum 1994;61:1-241.
8. Travis LB, Curtis RE, Glimelius B, et al. Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma. J Nat Cancer Inst 1995;87:524-30.
9. Madersbacher S, Hochreiter W, Burkhard F, et al. radical cystectomy for bladder cancer today-a homogeneous series without neoadjuvant therapy. J Clin Oncol 2003;4:690-6.
10. Ghoneim MA, Abdel-Latif M, El-Mekresh M, et al. Radical cystectomy for carcinoma of the bladder: 2, 720 consecutive cases 5 years later. J Urol 2008;180:121-7.
11. Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1, 054 patients. J Clin Oncol 2001;19:666-75.
12. World Health Organization (WHO) Consensus Conference on Bladder Cancer; Hautmann R, Abol-Enein H, Hafez K, et al. Urinary diversion. Urology 2007;69:17-49.
13. Kessler T. Attempted nerve-sparing surgery and age have a significant effect on urinary continence and erectile function after radical cystoprostatectomy and ileal orthotopic substitution. J Urol 2004;172:1323-7.
14. Shipley WU, Kaufman DS, Zehr E, et al. Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer. Urology 2002;60:62-7.
15. Skinner DG. The value of regional lymph node dissection in genitourinary cancer. Semin Surg Oncol 1989;5:235-9.
16. Dhar NB, Klein EA, Reuther AM, et al. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 2008;179:873-8.
17. Kassouf W, Aqarwal PK, Herr HW, et al. Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC. J Clin Oncol 2008;26:121-6.
18. Kassouf W, Leibovici D, Munsell MF, et al. Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy. J Urol 2006;176:53-7.
19. Herr HW, Bochner BH, Dalbagni G, et al. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 2002;167:1295-8.
20. Herr HW, Faulkner JR, Grossman HB, et al. Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol 2004;22:2781-9.
21. Coen JJ, Zietman AL, Kaufman DS, et al. Benchmarks achieved in the delivery of radiation therapy for muscle-invasive bladder cancer. Urol Oncol 2007;25:76-84.
22. Freiha F, Reese J, Torti FM. A randomized trial of radical cystectomy v. radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol 1996;155:495-9.
23. Stockle M, Meyenburg W, Wellek S, et al. Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study. J Urol 1992;148:302-7.
24. Skinner DG, Daniels JR, Russell CA, et al. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol 1991;145:459-64.
25. Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analyis of individual patient data; Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Eur Urol 2005;48:189-99.
26. Shariat SF, Karakiewicz PI, Palapattu GS, et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 2006;176:2414-22.
27. Milosevic M, Gospodarowicz M, Zietman AL, et al. Radiotherapy for bladder cancer. Urology 2007;69: 80-92.
28. Kachnic LA, Kaufman DS, Heney NM, et al. Bladder preservation by combined modality therapy for invasive bladder cancer. J Clin Oncol 1997;15:1022-9.
29. Shipley WU, Kaufman DS, Heney NM, et al. An update of selective bladder preservation by combined modality therapy for invasive bladder cancer. Eur Urol 1998;33:32-4.
30. Sauer R, Birkenhake S, Kuhn R, et al. Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer. Int J Radiat Oncol Biol Phys 1998;40: 121-7.
31. Housset M, Maulard C, Chretien Y, et al. Combined radiation and chemotherapy for invasive transitional cell carcinoma of the bladder: a prospective study. J Clin Oncol 1993;11:2150-7.
32. Dunst J, Sauer R, Schrott KM, et al. Organ-sparing treatment of advanced bladder cancer: a 10-year experience. Int J Radiat Oncol Biol Phys 1994;30:261-6.
33. Hautmann RE, de Petriconi R, Volkmer BG. Neobladder formation after pelvic irradiation. World J Urol 2009;27:57-62.
34. Hautmann RE. Complications and results after cystectomy in male and female patients with locally invasive bladder cancer. Eur Urol 1998; 33: 23-4.
35. Bochner BH, Figueroa AJ, Skinner EC, et al. Salvage radical cystoprostatectomy and orthotopic urinary diversion following radiation failure. J Urol 1998;160:29-33.
36. Gheiler EL, Wood DP Jr, Montie JE, et al. Orthotopic urinary diversion is a viable option in patients undergoing salvage cystoprostatectomy for recurrence prostate cancer after definitive radiation therapy. Urology 1997;50:580-4.
37. Nieder AM, Porter MP, Soloway MS. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study. J Urol 2008;180:2005-9.
38. Wolf H, Olsen PR, Hojgaard K. Urothelial dysplasia concomitant with bladder tumours: a determinant for future new occurrences in patients treated by full-course radiotherapy. Lancet 1985;1:1005-8.
39. Babjuk M, Oosterlinck W, Sylvester R, et al. EUA guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2008;54:303-14.
40. Vaidya A, Soloway MS, Hawke C, et al. de novo muscle-invasive bladder cancer: Is there a change in trend? J Urol 2001;165:47-50.
41. Herr HW, Sogani PC. Does early cystectomy improve the survival of patients with high risk superficial bladder tumours? J Urol 2001;166:1296-9.
42. Harland SJ, Kynaston H, Grigor K, et al. A randomized trial of radical radiotherapy for the management of pT1G3 NXM0 transitional cell carcinoma of the bladder. J Urol 2007;178:807-13.